Entire Transcript in Adobe Acrobat Format - National Reference ...

89
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Framingham samples could not be used in an encrypted
fashion, all right -- no, I should not say that -- you
would have to go to the IRB because in their very nature
they are not anonymized.
DR. OLD: Yes.
DR. GREIDER: Okay.
DR. OLD: Going back a little bit, I think that
the approach that this group took was how do we get these
samples used. This was the baseline, was if the samples
can be used how can we use them and they do say in here,
you know, if it says in the informed consent they are to be
destroyed this does not pertain at all so you cannot do
research period whether it is genetic or not.
DR. HOLTZMAN: And that was the backdrop -- it
is a backdrop assumption for us as well.
DR. OLD: Right. And so -- but I think that
the underlying premise of this is that somebody has done a
study somewhere on these samples, Framingham, Eric
Strongheart, Honolulu Heart, they are sitting there
somewhere. Somebody has done a study of nongenetics or
something and now somebody wants to come in and do
something genetic. And so the -- obviously the parent
study has identifiers. They are doing their study.
But the new person coming in, whether they are